MARC record from Internet Archive

LEADER: 04158cam 2200877 a 4500
001 ocm34646460
003 OCoLC
005 20191127213838.0
008 950731s1996 waua b 001 0 eng
010 $a 95079406
040 $aDNLM$beng$cDLC$dNLM$dSMC$dUBA$dNLGGC$dBAKER$dBTCTA$dYDXCP$dOCLCG$dHEBIS$dDEBBG$dOCLCO$dOCLCF$dOCLCQ$dER0$dOCLCQ$dNLC$dOCLCO$dOCLCA$dOCLCQ$dOCLCA$dAU@$dOCLCO$dUWO$dQE2$dOCLCQ
015 $aC 959320644
015 $aC95-932064-4
015 $a959320644$2can
016 $a(AMICUS)000014411416
016 7 $a947335161$2DE-101
016 7 $a9611122$2DNLM
019 $a35883131
020 $a0889371547
020 $a9780889371545
035 $a(OCoLC)34646460$z(OCoLC)35883131
042 $alccopycat
050 04 $aRC346$b.J34 1996
055 01 $aRC346
060 00 $a1996 G-741
060 10 $aWL 140$bJ25d 1996
082 00 $a616.8/0471$221
084 $a44.90$2bcl
084 $acci1icc$2lacc
084 $aXI 2200$2rvk
084 $aXI 2069$2rvk
084 $aYG 5000$2rvk
084 $aYH 5900$2rvk
100 1 $aJain, K. K.$q(Kewal K.)
245 10 $aDrug-induced neurological disorders /$cK.K. Jain.
260 $aSeattle :$bHogrefe & Huber,$c℗♭1996.
300 $avii, 389 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and indexes.
505 0 $aCh. 1. Epidemiology and Clinical Significance -- Ch. 2. Pathomechanism of Drug-Induced Neurological Disorders -- Ch. 3. Drug-Induced Encephalopathies -- Ch. 4. Drug-Induced Disorders of Consciousness -- Ch. 5. Drug-Induced Neuropsychiatric Disorders -- Ch. 6. Drug-Induced Headaches -- Ch. 7. Drug-Induced Seizures -- Ch. 8. Drug-Induced Movement Disorders -- Ch. 9. Drug-Induced Cerebrovascular Disorders -- Ch. 10. Drug-Induced Disorders of Cranial Nerves and Special Senses -- Ch. 11. Drug-Induced Peripheral Neuropathies -- Ch. 12. Drug-Induced Neuromuscular Disorders -- Ch. 13. Drug-Induced Myopathies -- Ch. 14. Diseases of the Spine and Spinal Cord -- Ch. 15. Drug-Induced Cerebellar Disorders -- Ch. 16. Drug-Induced Aseptic Meningitis -- Ch. 17. Drug-Induced Benign Intracranial Hypertension -- Ch. 18. Disorders of the Autonomic Nervous System -- Ch. 19. Drug-Induced Sleep Disorders -- Ch. 20. Eosinophilia Myalgia Syndrome -- Ch. 21. Serotonin Syndrome.
505 8 $aCh. 22. Drug-Induced Guillain-Barre Syndrome -- Ch. 23. Neuroleptic Malignant Syndrome -- Ch. 24. Subacute Myelo-Optico-Neuropathy (SMON) -- Ch. 25. Drug-Induced Pituitary Disorders.
650 0 $aNervous system$xDiseases$xEtiology.
650 0 $aNeuropharmacology.
650 0 $aDrugs$xSide effects.
650 12 $aNervous System Diseases$xchemically induced.
650 6 $aSyste me nerveux$xMaladies$xE tiologie.
650 6 $aNeuropharmacologie.
650 6 $aMe dicaments$xEffets secondaires.
650 7 $aDrugs$xSide effects.$2fast$0(OCoLC)fst00898912
650 7 $aNervous system$xDiseases$xEtiology.$2fast$0(OCoLC)fst01036106
650 7 $aNeuropharmacology.$2fast$0(OCoLC)fst01036458
650 17 $aZenuwstelselaandoeningen.$2gtt
650 17 $aGeneesmiddelen.$2gtt
650 17 $aBijwerkingen.$2gtt
650 17 $aNeurofarmacologie.$2gtt
650 7 $aArzneimittelschaden$2gnd
650 7 $aKrankheit$2gnd
650 7 $aNervensystem$2gnd
650 7 $aNeurologia.$2larpcal
776 08 $iOnline version:$aJain, K.K. (Kewal K.).$tDrug-induced neurological disorders.$dSeattle : Hogrefe & Huber, ℗♭1996$w(OCoLC)603913672
938 $aBaker & Taylor$bBKTY$c79.00$d79.00$i0889371547$n0002936188$sactive
938 $aBaker and Taylor$bBTCP$nBK0010343432
938 $aYBP Library Services$bYANK$n983674
029 1 $aAU@$b000012574213
029 1 $aAU@$b000023107374
029 1 $aAU@$b000045206622
029 1 $aDEBBG$bBV010780456
029 1 $aHEBIS$b054314569
029 1 $aNLC$b000014411416
029 1 $aNLGGC$b148289002
029 1 $aNLM$b9611122
029 1 $aNZ1$b4871317
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 84 OTHER HOLDINGS